Loading candles…
Emcure Pharmaceuticals Ltd, incorporated in 1981, is a vertically integrated pharmaceutical company that develops, manufactures, and markets a diverse range of pharmaceutical products. Its offerings include differentiated and complex generics across several key therapeutic areas such as gynaecology, cardiovascular, vitamins, minerals and nutrients, HIV/AIDS, and oncology. The company operates globally with significant presence in India, Europe, and Canada. Emcure holds a leading position in the Indian Pharmaceutical Market (IPM), notably as the largest player in gynaecology within the IPM and is recognized among the top 10 companies in this market. It has strong research and development capabilities and focuses on addressing unmet medical needs within the pharmaceutical industry.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 5 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 4 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 11 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 7 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 22 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.